From: Heterogeneous multimodal biomarkers analysis for Alzheimer’s disease via Bayesian network
Impo. | Supp. | Rule |
---|---|---|
y: MMSE | ||
100 | 0.78 | 61.85 <AGE<86.85 and HippoNV >0.38 |
91.3 | 0.81 | AGE <85.75 and FDG >5.78 |
74.6 | 0.15 | FDG <5.85 and AV45 >1.11 |
68.2 | 0.06 | EDU <19.5 and HippoNV <0.38 and APOE4=1 |
46.9 | 0.75 | 5.76 <FDG<7.25 |
y: ADAS-cog | ||
100 | 0.73 | FDG >5.75 and HippoNV >0.39 |
62.5 | 0.65 | FDG >4.9 and 1.02 <AV45 <1.51 |
41.2 | 0.72 | EDU <19.5 and HippoNV <0.55 |
41 | 0.44 | FDG >6.34 and rs3764650=0 |
35.9 | 0.17 | 1.23 <AV45 <1.63 and rs744373=0 |